|
1
|
Shields JA, Demirci H, Marr BP, Eagle RC
Jr and Shields CL: Sebaceous carcinoma of the ocular region: A
review. Surv Ophthalmol. 50:103–122. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Goto H, Yamakawa N, Komatsu H, Asakage M,
Tsubota K, Ueda SI, Nemoto R, Shibata M, Umazume K, Usui Y and Mori
H: Epidemiological characteristics of malignant eyelid tumors at a
referral hospital in Japan. Jpn J Ophthalmol. 66:343–349.
2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Goto H, Tsubota K, Nemoto R, Ueda S,
Umazume K, Usui Y and Matsumura H: Clinical features and prognosis
of sebaceous carcinoma arising in the eyelid or conjunctiva. Jpn J
Ophthalmol. 64:549–554. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shields JA, Demirci H, Marr BP, Eagle RC
Jr and Shields CL: Sebaceous carcinoma of the eyelids: Personal
experience with 60 cases. Ophthalmology. 111:2151–2157.
2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M,
Sagiv O, Kandl TJ and Esmaeli B: Prognostic factors for local
recurrence, metastasis, and survival for sebaceous carcinoma of the
eyelid: observations in 100 patients. Br J Ophthalmol. 103:980–984.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kaliki S, Ayyar A, Dave TV, Ali MJ, Mishra
DK and Naik MN: Sebaceous gland carcinoma of the eyelid:
clinicopathological features and outcome in Asian Indians. Eye
(Lond). 29:958–963. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Watanabe A, Sun MT, Pirbhai A, Ueda K,
Katori N and Selva D: Sebaceous carcinoma in Japanese patients:
Clinical presentation, staging and outcomes. Br J Ophthalmol.
97:1459–1463. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Choi YJ, Jin HC, Lee MJ, Kim N, Choung HK
and Khwarg SI: Prognostic value of clinical and pathologic T stages
defined by the American Joint Committee on Cancer for eyelid
sebaceous carcinoma in Korea. Jpn J Ophthalmol. 58:327–333.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mulay K, Aggarwal E and White VA:
Periocular sebaceous gland carcinoma: A comprehensive review. Saudi
J Ophthalmol. 27:159–165. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Muqit MM, Foot B, Walters SJ, Mudhar HS,
Roberts F and Rennie IG: Observational prospective cohort study of
patients with newly-diagnosed ocular sebaceous carcinoma. Br J
Ophthalmol. 97:47–51. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Takahashi Y, Takahashi E, Nakakura S,
Kitaguchi Y, Mupas-Uy J and Kakizaki H: Risk factors for local
recurrence or metastasis of eyelid sebaceous gland carcinoma after
wide excision with paraffin section control. Am J Ophthalmol.
171:67–74. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rao NA, Hidayat AA, McLean IW and
Zimmerman LE: Sebaceous carcinomas of the ocular adnexa: A
clinicopathologic study of 104 cases, with five-year follow-up
data. Hum Pathol. 13:113–122. 1982.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Esmaeli B, Nasser QJ, Cruz H, Fellman M,
Warneke CL and Ivan D: American Joint Committee on Cancer T
category for eyelid sebaceous carcinoma correlates with nodal
metastasis and survival. Ophthalmology. 119:1078–1082.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Muqit MM, Roberts F, Lee WR and Kemp E:
Improved survival rates in sebaceous carcinoma of the eyelid. Eye
(Lond). 18:49–53. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sa HS, Tetzlaff MT and Esmaeli B:
Predictors of local recurrence for eyelid sebaceous carcinoma:
questionable value of routine conjunctival map biopsies for
detection of pagetoid spread. Ophthalmic Plast Reconstr Surg.
35:419–425. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shields JA, Saktanasate J, Lally SE,
Carrasco JR and Shields CL: Sebaceous carcinoma of the ocular
region: the 2014 Professor Winifred Mao lecture. Asia Pac J
Ophthalmol (Phila). 4:221–227. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chao AN, Shields CL, Krema H and Shields
JA: Outcome of patients with periocular sebaceous gland carcinoma
with and without conjunctival intraepithelial invasion.
Ophthalmology. 108:1877–1883. 2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kaliki S, Vempuluru VS, Tanna V and Luthra
A: Eyelid and periocular sebaceous gland carcinoma: risk factors
for recurrence, exenteration, metastasis, and death in 355
patients. Can J Ophthalmol. 60:e395–e402. 2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gu X, Xie M, Luo Y, Song X, Xu S and Fan
X: Diffuse pattern, orbital invasion, perineural invasion, and
Ki-67 are associated with nodal metastasis in patients with eyelid
sebaceous carcinoma. Br J Ophthalmol. 107:756–762. 2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kaliki S, Morawala A, Dharap RS and
Mohamed A: Pagetoid tumour spread in periocular sebaceous gland
carcinoma: A comparative analysis in 130 patients. Eye (Lond).
35:2864–2870. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shields JA, Demirci H, Marr BP, Eagle RC
Jr, Stefanyszyn M and Shields CL: Conjunctival epithelial
involvement by eyelid sebaceous carcinoma. The 2003 J. Howard
Stokes lecture. Ophthalmic Plast Reconstr Surg. 21:92–96.
2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xu S, Moss TJ, Laura Rubin M, Ning J,
Eterovic K, Yu H, Jia R, Fan X, Tetzlaff MT and Esmaeli B:
Whole-exome sequencing for ocular adnexal sebaceous carcinoma
suggests PCDH15 as a novel mutation associated with metastasis. Mod
Pathol. 33:1256–1263. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
North JP, Golovato J, Vaske CJ, Sanborn
JZ, Nguyen A, Wu W, Goode B, Stevers M, McMullen K, Perez White BE,
et al: Cell of origin and mutation pattern define three clinically
distinct classes of sebaceous carcinoma. Nat Commun.
9(1894)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tetzlaff MT, Singh RR, Seviour EG, Curry
JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, et
al: Next-generation sequencing identifies high frequency of
mutations in potentially clinically actionable genes in sebaceous
carcinoma. J Pathol. 240:84–95. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Peterson C, Moore R, Hicks JL, Morsberger
LA, De Marzo AM, Zou Y, Eberhart CG and Campbell AA: NGS analysis
confirms common TP53 and RB1 mutations, and suggests MYC
amplification in ocular adnexal sebaceous carcinomas. Int J Mol
Sci. 22(8454)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bladen JC, Wang J, Sangaralingam A,
Moosajee M, Fitchett C, Chelala C, Beaconsfield M, O'Toole EA,
Philpott MP and Ezra DG: MicroRNA and transcriptome analysis in
periocular Sebaceous Gland Carcinoma. Sci Rep.
8(7531)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tetzlaff MT, Curry JL, Yin V,
Pattanaprichakul P, Manonukul J, Uiprasertkul M, Manyam GC, Wani
KM, Aldape K, Zhang L, et al: Distinct pathways in the pathogenesis
of sebaceous carcinomas implicated by differentially expressed
microRNAs. JAMA Ophthalmol. 133:1109–1116. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hirano T, Yunoki T, Furusawa Y, Tabuchi Y
and Hayashi A: Bioinformatics analysis of the microRNA-mRNA network
in sebaceous gland carcinoma of the eyelid. Mol Med Rep.
23(44)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chu M, Zhang Y, Chen J, Cong H, Yin Y and
Chen H: Breast cancer bone metastasis: Novel prognostic biomarkers
identified. Phenomics. 5:404–417. 2025.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhong MF, Luo YJ, Guo YY, Xiang S and Lin
WF: Jiedu Fang inhibits hypoxia-induced angiogenesis in
hepatocellular carcinoma by targeting Aurora A/STAT3/IL-8 signaling
pathway. J Integr Med. 23:683–693. 2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Furusawa Y, Yunoki T, Hirano T, Minagawa
S, Izumi H, Mori H, Hayashi A and Tabuchi Y: Identification of
genes and genetic networks associated with BAG3dependent cell
proliferation and cell survival in human cervical cancer HeLa
cells. Mol Med Rep. 18:4138–4146. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bhardwaj M, Sen S, Chosdol K, Sharma A,
Pushker N, Kashyap S, Bakhshi S and Bajaj MS: miRNA-200c and
miRNA-141 as potential prognostic biomarkers and regulators of
epithelial-mesenchymal transition in eyelid sebaceous gland
carcinoma. Br J Ophthalmol. 101:536–542. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhao H, Yang X, Liu J, Han F, Yang Z, Hu
Z, Liu M and Mei Y: Overexpression of miR-651-5p inhibits
ultraviolet radiation-induced malignant biological behaviors of
sebaceous gland carcinoma cells by targeting ZEB2. Ann Transl Med.
10(517)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang C, Zhu L, Liu X, Jiang M, Tang Q, Xu
F, Lin T, Dong L and He Y: MicroRNA-3907 promotes the proliferation
and migration of sebaceous gland carcinoma of the eyelid by
targeting thrombospondin 1. Oncol Lett. 22(833)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen C, Zhao S, Karnad A and Freeman JW:
The biology and role of CD44 in cancer progression: Therapeutic
implications. J Hematol Oncol. 11(64)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Anderson K, Ryan N, Nedungadi D, Lamenza
F, Swingler M, Siddiqui A, Satoskar A, Upadhaya P, Pietrzak M and
Oghumu S: STAT1 is regulated by TRIM24 and promotes
immunosuppression in head and neck squamous carcinoma cells, but
enhances T cell antitumour immunity in the tumour microenvironment.
Br J Cancer. 127:624–636. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Feng J, Li Y, Zhu L, Zhao Q, Li D, Li Y
and Wu T: STAT1 mediated long non-coding RNA LINC00504 influences
radio-sensitivity of breast cancer via binding to TAF15 and
stabilizing CPEB2 expression. Cancer Biol Ther. 22:630–639.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Garnis C, Davies JJ, Buys TP, Tsao MS,
MacAulay C, Lam S and Lam WL: Chromosome 5p aberrations are early
events in lung cancer: Implication of glial cell line-derived
neurotrophic factor in disease progression. Oncogene. 24:4806–4812.
2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lu DY, Leung YM, Cheung CW, Chen YR and
Wong KL: Glial cell line-derived neurotrophic factor induces cell
migration and matrix metalloproteinase-13 expression in glioma
cells. Biochem Pharmacol. 80:1201–1209. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tang XD, Zhang DD, Jia L, Ji W and Zhao
YS: lncRNA AFAP1-AS1 promotes migration and invasion of non-small
cell lung cancer via up-regulating IRF7 and the RIG-I-like receptor
signaling pathway. Cell Physiol Biochem. 50:179–195.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Juszczynski P, Kutok JL, Li C, Mitra J,
Aguiar RC and Shipp MA: BAL1 and BBAP are regulated by a gamma
interferon-responsive bidirectional promoter and are overexpressed
in diffuse large B-cell lymphomas with a prominent inflammatory
infiltrate. Mol Cell Biol. 26:5348–5359. 2006.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Tang X, Zhang H, Long Y, Hua H, Jiang Y
and Jing J: PARP9 is overexpressed in human breast cancer and
promotes cancer cell migration. Oncol Lett. 16:4073–4077.
2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lu Z, Huang X, Shen Q, Chen E and Feng Y:
Granzyme B promotes proliferation, migration, and EMT process in
gastric cancer. Biochem Genet. 63:2513–2529. 2025.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bennett J and Starczynowski DT: IRAK1 and
IRAK4 as emerging therapeutic targets in hematologic malignancies.
Curr Opin Hematol. 29:8–19. 2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Liu C, Yao Z, Wang J, Zhang W, Yang Y,
Zhang Y, Qu X, Zhu Y, Zou J, Peng S, et al: Macrophage-derived CCL5
facilitates immune escape of colorectal cancer cells via the
p65/STAT3-CSN5-PD-L1 pathway. Cell Death Differ. 27:1765–1781.
2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Motwani M, Pesiridis S and Fitzgerald KA:
DNA sensing by the cGAS-STING pathway in health and disease. Nat
Rev Genet. 20:657–674. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Verhoeven Y, Tilborghs S, Jacobs J, De
Waele J, Quatannens D, Deben C, Prenen H, Pauwels P, Trinh XB,
Wouters A, et al: The potential and controversy of targeting STAT
family members in cancer. Semin Cancer Biol. 60:41–56.
2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Langowski JL, Zhang X, Wu L, Mattson JD,
Chen T, Smith K, Basham B, McClanahan T, Kastelein RA and Oft M:
IL-23 promotes tumour incidence and growth. Nature. 442:461–465.
2006.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yu M, Lu B, Liu Y, Me Y, Wang L and Zhang
P: Tim-3 is upregulated in human colorectal carcinoma and
associated with tumor progression. Mol Med Rep. 15:689–695.
2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tokunaga R, Zhang W, Naseem M, Puccini A,
Berger MD, Soni S, McSkane M, Baba H and Lenz HJ: CXCL9, CXCL10,
CXCL11/CXCR3 axis for immune activation-a target for novel cancer
therapy. Cancer Treat Rev. 63:40–47. 2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jia M, Liu C, Liu Y, Bao Z, Jiang Y and
Sun X: Discovery and validation of a SIT1-related prognostic
signature associated with immune infiltration in cutaneous
melanoma. J Pers Med. 13(13)2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Liu MD, Wu H, Wang S, Pang P, Jin S, Sun
CF and Liu FY: MiR-1275 promotes cell migration, invasion and
proliferation in squamous cell carcinoma of head and neck via
up-regulating IGF-1R and CCR7. Gene. 646:1–7. 2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Kahlert C, Klupp F, Brand K, Lasitschka F,
Diederichs S, Kirchberg J, Rahbari N, Dutta S, Bork U, Fritzmann J,
et al: Invasion front-specific expression and prognostic
significance of microRNA in colorectal liver metastases. Cancer
Sci. 102:1799–1807. 2011.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Xie C, Wu Y, Fei Z, Fang Y, Xiao S and Su
H: MicroRNA-1275 induces radiosensitization in oesophageal cancer
by regulating epithelial-to-mesenchymal transition via
Wnt/beta-catenin pathway. J Cell Mol Med. 24:747–759.
2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Ou Z, Lu Y, Xu D and Luo Z: Hypoxia
mediates immune escape of pancreatic cancer cells by affecting
miR-1275/AXIN2 in natural killer cells. Front Immunol.
14(1271603)2023.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wang J, Ma G, Han X, Liang M, Wang X, Xia
T and Wang S: The low expression of miR-1976 in plasma samples
indicating its biological functions in the progression of breast
cancer. Clin Transl Oncol. 22:2111–2120. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Chen G, Hu J, Huang Z, Yang L and Chen M:
MicroRNA-1976 functions as a tumor suppressor and serves as a
prognostic indicator in non-small cell lung cancer by directly
targeting PLCE1. Biochem Biophys Res Commun. 473:1144–1151.
2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Chen L, Gao W, Lin L, Sha C, Li T, Chen Q,
Wei H, Yang M, Xing J, Zhang M, et al: A methylation- and
immune-related lncRNA signature to predict ovarian cancer outcome
and uncover mechanisms of chemoresistance. J Ovarian Res.
16(186)2023.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Cui LH, Xu HR, Yang W and Yu LJ: lncRNA
PCAT6 promotes non-small cell lung cancer cell proliferation,
migration and invasion through regulating miR-330-5p. Onco Targets
Ther. 11:7715–7724. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Gao Y, Wang F, Zhang L, Kang M, Zhu L, Xu
L, Liang W and Zhang W: LINC00311 promotes cancer stem-like
properties by targeting miR-330-5p/TLR4 pathway in human papillary
thyroid cancer. Cancer Med. 9:1515–1528. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Liu C, Huang Y, Cui Y, Zhou J, Qin X,
Zhang L, Li X, Li Y, Guo E, Yang B, et al: The immunological role
of CDK4/6 and potential mechanism exploration in ovarian cancer.
Front Immunol. 12(799171)2022.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Jakobiec FA and Mendoza PR: Eyelid
sebaceous carcinoma: clinicopathologic and multiparametric
immunohistochemical analysis that includes adipophilin. Am J
Ophthalmol. 157:186–208.e2. 2014.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Milman T, Schear MJ and Eagle RC Jr:
Diagnostic utility of adipophilin immunostain in periocular
carcinomas. Ophthalmology. 121:964–971. 2014.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Nishi S, Nishino H and Ishibashi T: cDNA
cloning of the mammalian sterol C5-desaturase and the expression in
yeast mutant. Biochim Biophys Acta. 1490:106–108. 2000.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Mundi MS, Velapati S, Patel J, Kellogg TA,
Abu Dayyeh BK and Hurt RT: Evolution of NAFLD and its management.
Nutr Clin Pract. 35:72–84. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Kang HW, Wei J and Cohen DE: PC-TP/StARD2:
Of membranes and metabolism. Trends Endocrinol Metab. 21:449–456.
2010.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Liu W, Liang B, Zeng J, Meng J, Shi L,
Yang S, Chang J, Wang C, Hu X, Wang X, et al: First discovery of
cholesterol-lowering activity of parthenolide as NPC1L1 inhibitor.
Molecules. 27(6270)2022.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Liu YK, Dong YH, Liang XM, Qiang S, Li ME,
Sun Z, Zhao X, Yan ZH and Zheng J: Application of integrated omics
in aseptic loosening of prostheses after hip replacement. Mol Med
Rep. 31(65)2025.PubMed/NCBI View Article : Google Scholar
|
|
69
|
García JG, Ansorena E, Milagro FI, Zalba G
and de Miguel C: Endothelial Nox5 expression modulates glucose
uptake and lipid accumulation in mice fed a high-fat diet and
3T3-L1 adipocytes treated with glucose and palmitic acid. Int J Mol
Sci. 22(2729)2021.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Maus M, Cuk M, Patel B, Lian J, Ouimet M,
Kaufmann U, Yang J, Horvath R, Hornig-Do HT,
Chrzanowska-Lightowlers ZM, et al: Store-operated Ca2+
entry controls the induction of lipolysis and the transcriptional
reprogramming to lipid metabolism. Cell Metab. 25:698–712.
2017.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Wan Y, Hudson R, Smith J, Forman-Kay JD
and Ditlev JA: Protein interactions, calcium, phosphorylation, and
cholesterol modulate CFTR cluster formation on membranes. Proc Natl
Acad Sci USA. 122(e2424470122)2025.PubMed/NCBI View Article : Google Scholar
|
